Over the years, the total number of scientific publications in drug discovery in Singapore has shown considerable volatility, with the highest point in 2014 and a significant decline occurring thereafter. As of 2023, the number of publications stood at 18.41 units. The year-on-year variation for the last two years shows a slight increase in 2022 by 4%, followed by a decrease of 0.81% in 2023. The compound annual growth rate (CAGR) over the last five years indicates a downward trend with an average annual decline of 3.59%.
Looking forward, forecasted data indicates a continuing decline in the number of publications, with a forecasted five-year CAGR of -2.06%, resulting in an expected 9.91% overall decrease by 2028.
Trends to watch for in the future include:
- Investment in R&D and potential impact on publication output.
- Policy changes or funding shifts that might influence research activity.
- Emergence of new research institutions or collaborations.
- Technological advancements and their role in accelerating research and publication.
